Experts Warn HHS Vaccine Policy Changes Violate Law and Endanger Health

Feb 11, 2026, 2:35 AM
Image for article Experts Warn HHS Vaccine Policy Changes Violate Law and Endanger Health

Hover over text to view sources

Legal and public health experts have issued a strong warning regarding the recent decisions made by the US Department of Health and Human Services (HHS) to downgrade several vaccine recommendations. A brief filed in the case American Academy of Pediatrics et al. Kennedy outlines how these changes not only violate established federal laws but also pose a serious risk to public health, especially for vulnerable populations like children and pregnant individuals.
The HHS has notably downgraded the COVID-19 vaccine from a "routine" recommendation for all individuals aged six months and older. This has raised concerns about the potential increase in preventable diseases, as the agency has also dropped longstanding recommendations for universal hepatitis B vaccinations for newborns and reduced the number of childhood vaccines recommended for routine use from 17 to 11. Public health experts emphasize that vaccines have historically played a crucial role in preventing serious illnesses and deaths.
The implications of these changes are alarming. Joshua Sharfstein, a former FDA official and one of the legal scholars involved in the case, stated, "The law simply does not permit HHS to change vaccine recommendations for millions of American families on a dime." He stressed the importance of thorough evidence consideration and public discussion when it comes to vaccine policy, particularly as it affects children's health.
Furthermore, the shift in HHS's vaccine recommendations to a category known as "shared clinical decision-making" has created confusion for both families and healthcare providers. This designation is usually reserved for situations where the evidence regarding the risks and benefits of vaccination is unclear. Experts argue that this move undermines the established frameworks that govern vaccine policy, which require extensive public input and evidence gathering.
The recent lawsuit filed by the American Public Health Association (APHA) and several medical organizations challenges these changes, claiming they put Americans "at grave and immediate risk" of harm. The lawsuit specifically targets Secretary Robert F. Kennedy Jr for his role in these decisions, noting that he has a history of spreading vaccine misinformation. Critics argue that such actions not only contravene federal procedures but also threaten the integrity of public health initiatives designed to protect the population.
The legal complaint highlights that the directive issued by Kennedy lacks a solid scientific basis. According to experts, the COVID-19 vaccines have been shown through peer-reviewed studies to be safe and effective for children and pregnant individuals. The lawsuit asserts that the new guidance creates significant challenges for healthcare providers, who now find themselves in conflicting positions regarding vaccine recommendations.
Susan Kressly, president of the American Academy of Pediatrics, expressed concern that undermining vaccine recommendations could weaken the nation's vaccination infrastructure even further. She stated, "These actions are creating confusion around proven vaccines and the science supporting them," thereby endangering children's health and contributing to the spread of preventable diseases.
The lawsuit against HHS is part of a broader effort by public health advocates to restore trust in vaccinations and combat the rising tide of vaccine hesitancy exacerbated by misinformation. As vaccination rates decline, particularly among children, health officials warn of a potential resurgence of diseases that have been largely controlled through immunization.
In summary, the ongoing legal battles and public health warnings underscore the critical need for transparency, evidence-based policymaking, and adherence to established legal frameworks in the realm of vaccine recommendations. The health and well-being of millions depend on these decisions, and experts are calling for immediate action to rectify the changes made by HHS.

Related articles

Former FDA Chief Critiques HHS for Policy-Based Evidence Approach

Dr Robert M. Califf, former FDA Commissioner, has expressed concerns regarding the current leadership of the Department of Health and Human Services (HHS), suggesting that it emphasizes policy-based evidence rather than evidence-based policy. This shift may undermine public health initiatives and the integrity of vaccine recommendations.

SC Senator Proposes Bill to Eliminate Religious Exemptions for Measles Vaccine

South Carolina State Senator Margie Bright Matthews has introduced a bill to abolish religious exemptions for the measles vaccine, aiming to improve public health amid a significant outbreak in the state. The proposal has sparked debate, with critics arguing it infringes on religious freedoms.

Trust in CDC at Low Point Amid Vaccine Schedule Changes

A recent KFF Tracking Poll reveals a significant decline in public trust towards the CDC, with less than half of Americans expressing confidence in the agency's vaccine guidance. The poll highlights partisan divides regarding the newly revised childhood vaccination schedule, with many expressing concerns about its impact on children's health.

President Trump Launches TrumpRx to Make Medicines More Affordable

On February 5, President Donald Trump unveiled TrumpRx, a new initiative aimed at providing cost-effective medications to Americans. The program, set to launch in 2026, is expected to significantly reduce prices for popular GLP-1 weight loss medications, making them accessible to more individuals.

CT Health Commissioner Supports Pediatric Vaccine Guidelines Over CDC

Connecticut Health Commissioner Manisha Juthani has endorsed the American Academy of Pediatrics' vaccine recommendations, diverging from recent changes made by the CDC. This decision reflects a broader movement among several states to prioritize evidence-based vaccine policies amid federal uncertainties.